Health Technology/clinical-trials

AI-Enhanced Lung Cancer Screening Trial: Deep Learning Tool Aims to Boost CT Uptake in High-Risk Patients

247 Health News Editorial

·

17 May 2026

·

4 min read

·clinical-trials

New clinical trial evaluates AI tool that analyses chest X-rays to identify high-risk lung cancer patients and improve screening CT participation rates. The CXR-LC system could transform early detection strategies by identifying at-risk individuals missed by current guidelines.

Originally reported by ClinicalTrials.gov

References

  1. 1.Massachusetts General Hospital. (2024). Deep Learning Using Routine Chest X-Rays and Electronic Medical Record Data to Identify High Risk Patients for Lung Cancer Screening CT. ClinicalTrials.gov. NCT06910956. https://clinicaltrials.gov/study/NCT06910956
  2. 2.National Lung Screening Trial Research Team. (2011). Reduced lung-cancer mortality with low-dose computed tomographic screening. New England Journal of Medicine, 365(5), 395-409. https://doi.org/10.1056/NEJMoa1102873
  3. 3.Moyer, V. A. (2014). Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 160(5), 330-338. https://doi.org/10.7326/M13-2771
  4. 4.Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023). Cancer statistics, 2023. CA: A Cancer Journal for Clinicians, 73(1), 233-254. https://doi.org/10.3322/caac.21763
  5. 5.Richards, T. B., Doria-Rose, V. P., Soman, A., et al. (2020). Lung cancer screening inconsistent with U.S. Preventive Services Task Force recommendations. American Journal of Preventive Medicine, 58(2), 246-254. https://doi.org/10.1016/j.amepre.2019.07.030
Share:XLinkedIn
2

247 Health News Editorial

247 Health News is a medical intelligence platform delivering evidence-based research appraisals, clinical trial monitoring, and health technology news for healthcare professionals.

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service